Skip to main content
    A

    Aprea Therapeutics Inc (APRE)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.45
    +0.05 (+11.52%)

    Market Cap: $5.91M

    Last updated: Nov 17, 2026 at 4:17 PM ET

    Aprea Therapeutics Inc (APRE) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Aprea Therapeutics (APRE) has a market cap of $5.91M. It kept -423878.66% of revenue as net income over the last 12 months. Its share count is up 742.33% from a year earlier.

    Total Valuation

    Market Cap$5.91M
    Latest price (Nov 17, 2026)$0.45

    Key Dates

    The next earnings report is expected on Mar 15, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 15, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.37% in the quarter ended Sep 30, 2026 and grew 200.63% a year over 2 years.

    Shares Outstanding53.68M
    Shares Change (YoY)+742.33%
    Shares Change (QoQ)+0.37%
    Share Count Growth (2Y CAGR)+200.63%

    Price Statistics

    The stock is down 62.55% over 52 weeks and trades 26.23% below its 50-day average.

    Beta (1Y)0.68
    52-Week Change-62.55%
    1-Month Change-14.88%
    3-Month Change-32.47%
    6-Month Change-43.36%
    5-Year Change-99.51%
    Total Return (1Y)-62.55%
    Total Return (3Y CAGR)-50.64%
    Total Return (5Y CAGR)-64.92%
    Max Drawdown (1Y)-67.75%
    Max Drawdown (3Y)-95.20%
    Sharpe Ratio (1Y)-1.03
    Correlation with SPY (1Y)0.10
    50-Day Average$0.61
    200-Day Average$0.73
    52-Week Range$0.40 to $1.29
    RSI (14 Days)40.2
    Average Volume (20 Days)223.19K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 9.67x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio9.67x
    Quick Ratio9.67x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -41.47% and return on assets is -36.44% over the last 12 months.

    Return on Equity (ROE)-41.47%
    Return on Assets (ROA)-36.44%
    Asset Turnover0.00x

    Scores

    APRE has an Altman Z-Score of -9.00, in the distress zone below 1.81, and a Piotroski F-Score of 0 of 9, in the weak band of 0 to 2.

    Altman Z-Score-9.00
    Altman Z ZoneDistress
    Piotroski F-Score0 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $3.34K over the last 12 months is down 99.32% from the 12 months before.

    Revenue$3.34K
    Revenue Growth (YoY)-99.32%
    Gross Profit$3.34K
    Operating Income-$15.28M
    Pretax Income-$14.14M
    Net Income-$14.14M
    Reported EPS (TTM)-$0.70

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 87.89% of the $38.81M in total assets.

    Cash and Equivalents$37.85M
    Total Debt$0
    Net Cash$37.85M
    Net Cash Per Share$0.71
    Working Capital$34.46M
    Shareholder Equity$34.11M
    Book Value Per Share$0.64
    Total Assets$38.81M
    Total Liabilities$3.97M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$12.72M
    FCF Per Share-$1.01
    Depreciation and Amortization$22.51K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -457872.76%.

    Gross Margin100.00%
    Operating Margin-457872.76%
    Pretax Margin-423878.66%
    Net Margin-423878.66%

    Growth

    Book Value Per Share Growth (2Y CAGR)-40.28%
    Tangible Book Per Share Growth (2Y CAGR)-40.28%

    Revenue and profit by year

    Dividends and Yields

    APRE does not pay a dividend.

    Buyback Yield-150.18%
    Shareholder Yield-150.18%

    Stock Splits

    The last split was a 1-for-20 reverse split on Feb 13, 2023.

    Last Split DateFeb 13, 2023
    Split TypeReverse split
    Split Ratio1:20

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About APRE

    What is APRE's market cap?

    Aprea Therapeutics has a market cap of $5.91M.

    How many shares of APRE are outstanding?

    Aprea Therapeutics has 53.68M shares outstanding. The count is up 742.33% from a year earlier.

    Does APRE pay a dividend?

    No. Aprea Therapeutics does not pay a dividend.

    How much debt does APRE have?

    Aprea Therapeutics has $0 of total debt and $37.85M of cash and equivalents, a net cash position of $37.85M.